These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3770045)

  • 41. Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study.
    Costanzi JJ; Fletcher WS; Balcerzak SP; Taylor S; Eyre HJ; O'Bryan RM; Al-Sarraf M; Frank J
    Cancer; 1984 Feb; 53(4):833-6. PubMed ID: 6362830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma.
    Legha SS; Ring S; Papadopoulos N; Plager C; Chawla S; Benjamin R
    Cancer; 1989 Nov; 64(10):2024-9. PubMed ID: 2804890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum.
    Fritze D; Massner B; Becher R; Kaufmann M; Illiger HJ; Hartlapp J; Queisser W; Abel U; Edler L; Mayr AC
    Klin Wochenschr; 1984 Feb; 62(4):162-7. PubMed ID: 6368960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.
    Thatcher N; Honeybourne D; Wagstaff J; Carroll KB; Barber PV; Morrison JB; Crowther D
    Br J Dis Chest; 1984 Jan; 78(1):89-97. PubMed ID: 6318791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
    Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study.
    Jelić S; Babović N; Stamatović L; Kreacić M; Matković S; Popov I
    Med Oncol; 2001; 18(3):189-95. PubMed ID: 11917943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II study.
    Stoter G; Shiloni E; Aamdal S; Cleton FJ; Iacobelli S; Bijman JT; Palmer P; Franks CR; Rodenhuis S
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S41-3. PubMed ID: 2697578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Docetaxel in combination with dacarbazine in patients with advanced melanoma.
    Bafaloukos D; Aravantinos G; Fountzilas G; Stathopoulos G; Gogas H; Samonis G; Briasoulis E; Mylonakis N; Skarlos DV; Kosmidis P
    Oncology; 2002; 63(4):333-7. PubMed ID: 12417787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sequential dacarbazine chemotherapy followed by recombinant interleukin-2 in metastatic melanoma. A pilot multicentre phase I-II study.
    Shiloni E; Pouillart P; Janssens J; Splinter T; Di Peri T; Symann M; Roest GJ; Palmer PA; Franks CR
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S45-9. PubMed ID: 2697579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule.
    Pritchard KI; Quirt IC; Cowan DH; Osoba D; Kutas GJ
    Cancer Treat Rep; 1980; 64(10-11):1123-6. PubMed ID: 7459898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
    Agarwala SS; Ferri W; Gooding W; Kirkwood JM
    Cancer; 1999 May; 85(9):1979-84. PubMed ID: 10223239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-dose dacarbazine and dactinomycin in advanced malignant melanoma.
    Hochster H; Levin M; Speyer J; Dunleavy S; Harris M; Roses D; Golomb F; Muggia F
    Cancer Treat Rep; 1985 Jan; 69(1):39-42. PubMed ID: 3967259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.
    Flaherty LE; Redman BG; Chabot GG; Martino S; Gualdoni SM; Heilbrun LK; Valdivieso M; Bradley EC
    Cancer; 1990 Jun; 65(11):2471-7. PubMed ID: 2337862
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corynebacterium parvum versus bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma.
    Lipton A; Harvey HA; Balch CM; Antle CE; Heckard R; Bartolucci AA
    J Clin Oncol; 1991 Jul; 9(7):1151-6. PubMed ID: 2045856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma.
    Murren JR; DeRosa W; Durivage HJ; Davis C; Makuch R; Portlock CS
    Cancer; 1991 Mar; 67(6):1514-7. PubMed ID: 2001539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma.
    Bar J; Yerushalmi R; Shapira-Frummer R; Kutchuk I; Sulkes A; Gutman H; Catane R; Schachter J
    Oncol Rep; 2008 Dec; 20(6):1533-8. PubMed ID: 19020738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group.
    Cancer; 1989 May; 63(9):1676-80. PubMed ID: 2467736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
    Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N
    J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.